Werewolf Therapeutics (HOWL) Stock Soars 127% on Ambros Merger and $150M Financing Deal
Werewolf Therapeutics (HOWL) stock surged 127% premarket after unveiling Ambros merger, $150M capital raise, and $33M EMD Serono asset sale agreement.
The post Werewolf Therapeutics (HOWL) Stock Soars 127% on Ambros Merger and $150M Financing Deal appeared first on Blockonomi.
Source: Source: Blockonomi